Skip to main content
  • About
  • Careers
  • Locations
ArentFox Schiff

Main navigation

  • Attorneys
  • Industries & Practices
  • Insights
Search the Site Search the Site
Toggle Main Menu

Main navigation

  • Attorneys
  • Industries & Practices
  • Insights
    • Blogs
    • Alerts
    • Events
    • News
    • The Fine Print
    • Fashion Counsel
    • Press Releases
    • Health Care Counsel Blog
    • Managing Automotive Blog
    • AI Law Blog
    • Customs & Import Compliance Blog
    • Trade Secrets Case Watch
    • Trump’s Policy Playbook
    • Consumer Products Watch
    • Environmental Law Advisor
    • Energy & Cleantech Counsel
    • The In-House Advisor
    • International Arbitration & Dispute Resolution Blog
    • Investigations Blog
    • National Security Counsel
    • Privacy Counsel

Footer

  • About
    • Leadership
    • Alumni
    • Diversity
    • Pro Bono
  • Careers
    • Attorney Opportunities
    • Professional Opportunities
    • Summer Program
  • Locations
    • Washington, DC
    • Chicago
    • New York
    • Los Angeles
    • Boston
    • San Francisco
    • Lake Forest
    • Ann Arbor
    • Decentraland
  • Contact
    • Client Payments
    • Subscribe

Search

Breadcrumb

  1. Services
  2. Health Care

Insights on Health Care

1231 total results. Page 29 of 50.

Investigations Blog
Health Care Company Agrees to $1.41 Million Settlement of FCA Claims
February 14, 2020
D. Jacques Smith, Randall A. Brater, Alexander S. Birkhold, Michael F. Dearington, Rebecca W. Foreman, Nadia Patel, Laura Zell

Headlines that Matter for Companies and Executives in Regulated Industries

Health Care Counsel Blog
New York Updates and Clarifies Policies Regarding Medication Administration for Hospice Patients Residing in Adult Care Facilities
February 13, 2020

On February 12, 2020, the New York State Department of Health (DOH) issued a Dear Administrator Letter clarifying DOH’s policies for hospice patients residing in adult care facilities (ACF) when those ACF Hospice Residents are no longer capable of self-administration of medications.

Health Care Counsel Blog
CMS Moves to Expand Medicare Advantage Program Access to Individuals with End-Stage Renal Disease
February 10, 2020
David S. Greenberg

On February 5, 2020, the Centers for Medicare and Medicaid Services (CMS) proposed removing long-standing prohibitions and eligibility restrictions that had barred many individuals with End-Stage Renal Disease (ESRD) from participating in the Medicare Advantage program.

Investigations Blog
Four Physicians Found Guilty for Role in $150 Million Medicare Fraud Scheme
February 7, 2020
D. Jacques Smith, Randall A. Brater, Alexander S. Birkhold, Michael F. Dearington, Rebecca W. Foreman, Nadia Patel, Laura Zell

Headlines that Matter for Companies and Executives in Regulated Industries

Health Care Counsel Blog
DOJ Goes After The Dark Side of Artificial Intelligence (AI)
February 4, 2020
Thomas E. Jeffry, Jr.

A software developer of an electronic health records system utilizing AI is the recent target in a DOJ fraud investigation.

Health Care Counsel Blog
New Year, New Reporting Requirements: California Entities Must Report Certain Patient Complaints of Sexual Abuse and Misconduct by Healing Arts Licensees
February 3, 2020

Spurred by physician sexual misconduct and abuse at high-profile institutions, California now requires clinics, health facilities, and “other entities” to report certain written allegations of a health care professional’s sexual misconduct to the professional’s licensing agency.

Investigations Blog
Health Information Technology Developer to Pay $145 Million to Resolve Kickback Allegations
January 31, 2020
D. Jacques Smith, Stephanie Trunk, Randall A. Brater, Alexander S. Birkhold, Michael F. Dearington, Rebecca W. Foreman, Nadia Patel, Laura Zell

Headlines that Matter for Companies and Executives in Regulated Industries

Health Care Counsel Blog
Deputy Associate Attorney General Sheds Light on DOJ’s FCA Priorities at Annual False Claims Act Conference
January 30, 2020
D. Jacques Smith, Randall A. Brater, Nadia Patel, Laura Zell

The health care industry continues to be a top priority of the Justice Department with respect to False Claims Act enforcement. In the meantime, investment in a robust compliance program may pay off in cooperation credits to mitigate a False Claims violation.

Investigations Blog
Deputy Associate Attorney General Sheds Light on DOJ’s FCA Priorities at Annual False Claims Act Conference
January 30, 2020
D. Jacques Smith, Randall A. Brater, Nadia Patel, Laura Zell

“Enforcing the False Claims Act is a top priority for the Department—not just for our office,” said Deputy Associate Attorney General Stephen Cox, the Keynote Speaker for the 2020 Advanced Forum on False Claims and Qui Tam Enforcement, hosted by the American Conference Institute.  Deputy Cox reflect

Health Care Counsel Blog
Drug Manufacturers Take Note: Oregon Proposes New Guidance Related to Price Reporting
January 27, 2020
Stephanie Trunk

The Oregon Department of Consumer and Business Services (the Department) issued a proposed bulletin on January 26 that seeks to provide guidance to drug manufacturers regarding the Department’s interpretation of what constitutes a “new prescription drug” for purposes of price reporting.

Investigations Blog
Home Health Care Employees Plead Guilty in Multi-Million Dollar Medicaid Fraud Scheme
January 24, 2020
D. Jacques Smith, Stephanie Trunk, Randall A. Brater, Alexander S. Birkhold, Michael F. Dearington, Rebecca W. Foreman, Nadia Patel, Laura Zell

Headlines that Matter for Companies and Executives in Regulated Industries

Health Care Feature Story Image
Investigations Blog
Health Care Industry Remains in DOJ Fraud and Abuse Crosshairs
January 22, 2020
D. Jacques Smith, Randall A. Brater, Michael F. Dearington

The federal government revealed in a recent report that of the $3 billion it recovered last year from companies charged with fraud and abuse, more than $2.6 billion involved the health care industry, marking the tenth consecutive year that the Department of Justice recovered more than $2 billion fro

Investigations Blog
Manufacturer to Pay Over $37.5 Million to Resolve False Claims Act Allegations
January 17, 2020
D. Jacques Smith, Stephanie Trunk, Randall A. Brater, Alexander S. Birkhold, Michael F. Dearington, Rebecca W. Foreman, Nadia Patel, Laura Zell

Headlines that Matter for Companies and Executives in Regulated Industries

Investigations Blog
Government Intervenes Against Integrated Health Care System in False Claims Act Suit
January 10, 2020
D. Jacques Smith, Stephanie Trunk, Randall A. Brater, Alexander S. Birkhold, Michael F. Dearington, Rebecca W. Foreman, Nadia Patel, Laura Zell

Headlines that Matter for Companies and Executives in Regulated Industries

Health Care Counsel Blog
CBI’s Medicaid and Government Pricing Congress
January 8, 2020
Stephanie Trunk

Health Care Co-Leader Stephanie Trunk will present at CBI’s Medicaid and Government Pricing Congress.

Health Care Feature Story Image
Health Care Counsel Blog
Happy New Year, PAs and Supervising Physicians! Amendments to the California Physician Assistant Practice Act Simplify Supervision Requirements
January 6, 2020

In welcome news to most anyone who supervises, employs, credentials, or is a physician assistant, amendments to California Business and Professions Code Section 3500 et seq., effective January 1, 2020, significantly simplify the supervision requirements for PAs in California.

Investigations Blog
Major Retail and Health Care Company Faces Fraudulent Billing Lawsuit
December 20, 2019
D. Jacques Smith, Stephanie Trunk, Randall A. Brater, Alexander S. Birkhold, Michael F. Dearington, Rebecca W. Foreman, Nadia Patel, Laura Zell

Headlines that Matter for Companies and Executives in Regulated Industries

Investigations Blog
Ten Former NFL Players Charged with Defrauding League's Health Care Benefits Plan
December 13, 2019
D. Jacques Smith, Stephanie Trunk, Randall A. Brater, Alexander S. Birkhold, Michael F. Dearington, Rebecca W. Foreman, Nadia Patel, Laura Zell

Headlines that Matter for Companies and Executives in Regulated Industries

Health Care Counsel Blog
Update: California Court of Appeal Orders Publication of Natarajan V. Dignity Health
December 9, 2019
Lowell C. Brown, Debra Albin-Riley

Natarajan addressed an important question: When may physicians who are the subject of a peer review hearing challenge the hearing officer in their cases on the ground that the hearing officer is biased?

Investigations Blog
Defense Vehicle Manufacturer Accused of Defrauding the Government by $1.2 Billion
December 6, 2019
D. Jacques Smith, Stephanie Trunk, Randall A. Brater, Alexander S. Birkhold, Michael F. Dearington, Rebecca W. Foreman, Nadia Patel, Laura Zell

Headlines that Matter for Companies and Executives in Regulated Industries

Health Care Counsel Blog
The “Reasonable Licensee” Defense – When Things Go Wrong Despite A Health Facility’s Reasonable Steps To Do Things Right
December 5, 2019
Thomas E. Jeffry, Jr.

The California Court of Appeal gave licensees of health care facilities good news by expanding the scope of the “reasonable licensee” defense when the California Department of Public Health (CDPH) issues a citation and imposes penalties.

Health Care Counsel Blog
CMS Proposes Increased Scrutiny of Medicaid Supplemental Payments and Related State Financing Arrangements
November 25, 2019
Anne M. Murphy

In what is widely considered to signal intensified focus by the Federal government on Medicaid supplemental payments and related State Medicaid financing mechanisms, the CMS on November 18, 2019 proposed the Medicaid Financing and Accountability Regulation.

Investigations Blog
Kentucky Hospital Agrees to Pay $10 Million to Resolve False Claims Act Allegations
November 22, 2019
D. Jacques Smith, Stephanie Trunk, Randall A. Brater, Alexander S. Birkhold, Michael F. Dearington, Rebecca W. Foreman, Nadia Patel, Laura Zell

Headlines that Matter for Companies and Executives in Regulated Industries

Health Care Counsel Blog
CMS Kicks the Can Down the Road
November 21, 2019
Stephanie Trunk

CMS issued an Interim Final Rule with comment period that further delays the inclusion of the US territories in the definitions of “States” and “United States” for purposes of the Medicaid Drug Rebate Program from April 1, 2020 until April 1, 2022.

Investigations Blog
Compound Ingredient Supplier to Pay Over $22 Million to Resolve Allegations Brought Under Qui Tam Provisions of FCA
November 15, 2019
D. Jacques Smith, Stephanie Trunk, Randall A. Brater, Alexander S. Birkhold, Michael F. Dearington, Rebecca W. Foreman, Nadia Patel, Laura Zell

Headlines that Matter for Companies and Executives in Regulated Industries

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 25
  • Page 26
  • Page 27
  • Page 28
  • Current page 29
  • Page 30
  • Page 31
  • Page 32
  • Page 33
  • …
  • Next page Next ›
  • Last page Last »

Footer

  • About
    • Leadership
    • Alumni
    • Diversity
    • Pro Bono
  • Careers
    • Attorney Opportunities
    • Professional Opportunities
    • Summer Program
  • Locations
    • Washington, DC
    • Chicago
    • New York
    • Los Angeles
    • Boston
    • San Francisco
    • Lake Forest
    • Ann Arbor
    • Decentraland
  • Contact
    • Client Payments
    • Subscribe

Social

Linkedin Twitter Youtube

Sub footer

  • Disclaimer
  • Privacy Policy
  • Terms of Use
  • Accessibility
  • Non Discrimination

© Copyright 2026 ArentFox Schiff LLP. All Rights Reserved.

Back to Top